Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (42,761,000)	$ (4,554,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	394,000	66,000
Stock-based compensation	121,000	434,000
Non-cash lease expense	0	311,000
Accretion of discount on senior note receivable	(952,000)	0
Amortization of debt discount and debt issuance costs	179,000	86,000
Non-cash expense related to equity consideration for services	0	189,000
Loss on ELOC commitment note and derivative liability	14,965,000	590,000
Loss on impairment of intangible assets	16,130,000	0
Loss on sale and disposal of property and equipment	0	0
Loss on settlement of deposit	650,000	0
Loss on debt issuances	7,437,000	0
Gain on debt extinguishment	(52,000)	(14,591,000)
Deferred income tax benefit	(3,226,000)	0
Unrealized loss (gain) on foreign exchange rate changes	376,000	(180,000)
Change in fair value of convertible notes	(3,473,000)	0
Change in fair value of derivative liabilities	(801,000)	(33,000)
Change in fair value of senior secured notes	0	150,000
Change in fair value of warrant liability	(292,000)	(2,166,000)
Prepaid expenses and other current assets	527,000	(11,000)
Accounts payable	(228,000)	1,245,000
Accrued expenses	122,000	48,000
Operating lease liabilities	(377,000)	(345,000)
Other current liabilities	(174,000)	(375,000)
Net cash used in operating activities	(11,436,000)	(11,717,000)
Cash flows from investing activities:
Issuance of senior note	(4,572,000)	0
Deposit	(1,400,000)	0
Proceeds from sale of property and equipment	0	0
Purchase of property and equipment	0	(12,000)
Net cash used in investing activities	(5,972,000)	(12,000)
Cash flows from financing activities:
Proceeds from convertible notes	4,303,000	0
Proceeds from senior secured notes payable	500,000	0
Proceeds from exercise of common stock warrants	353,000	0
Principal payments on senior secured notes payable	(600,000)	0
Principal payments on loans payable	(407,000)	(344,000)
Cash dividend payments on Series C preferred stock	(90,000)	(347,000)
Proceeds from ATM Program, net of issuance costs	0	1,367,000
Proceeds from senior convertible notes payable, net of issuance costs	0	1,312,000
Principal payments on senior convertible notes payable	(2,200,000)	(150,000)
Proceeds from senior secured and unsecured notes, net of issuance costs	0	550,000
Issuance costs related to Series B Preferred Stock	0	(68,000)
Payments on debt extinguishment	0	(200,000)
Net cash provided by financing activities	15,833,000	9,569,000
Net decrease in cash, cash equivalents, and restricted cash	(1,574,000)	(2,160,000)
Cash, cash equivalents, and restricted cash - beginning of period	1,788,000	4,469,000
Cash, cash equivalents, and restricted cash - end of period	214,000	2,309,000
Supplementary disclosure of non-cash activity:
Private placement proceeds allocated to common stock warrant liability	0	3,331,000
Non-cash issuance costs allocated to Series C preferred stock	0	37,000
Deemed Dividends, Warrants	9,000	(0)
Cash dividends payable	141,000	0
Cash dividends converted into common stock	105,000	0
Fair value upon issuance of common stock warrant liability	0	10,787,000
Settlement of common stock warrant liability	20,000	0
Prepayment of insurance through third-party financing	0	555,000
Conversion of Notes into Common Stock [Member]
Supplementary disclosure of non-cash activity:
Issuance of common stock, note conversions	0	280,000
Fair value of common stock consideration related to ELOC commitment note extinguishment	0	280,000
March 2025 Senior Secured Notes [Member]
Supplementary disclosure of non-cash activity:
Fair value upon issuance of convertible notes	374,000	0
June 2025 Warrants [Member]
Supplementary disclosure of non-cash activity:
Fair value upon issuance of common stock warrant liability	2,930,000	0
June 2025 Notes [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of convertible notes	(3,500,000)
Supplementary disclosure of non-cash activity:
Fair value upon issuance of convertible notes	8,566,000	0
Senior Convertible Notes [Member]
Supplementary disclosure of non-cash activity:
Fair value upon issuance of derivative liability related to senior convertible notes payable	0	458,000
Embedded Derivative Financial Instruments, Convertible Promissory Note [Member]
Supplementary disclosure of non-cash activity:
Issuance of common stock, note conversions	0	284,000
Fair value of common stock consideration related to ELOC commitment note extinguishment	0	284,000
Conversion of Notes into Common Stock [Member]
Supplementary disclosure of non-cash activity:
Issuance of common stock, note conversions	377,000	0
Fair value of common stock consideration related to ELOC commitment note extinguishment	377,000	0
ELOC Purchase Agreement [Member]
Cash flows from financing activities:
Proceeds from ELOC Purchase Agreement, net of issuance costs	15,849,000	4,371,000
Supplementary disclosure of non-cash activity:
Issuance of common stock, note conversions	476,000	0
Fair value of common stock consideration related to ELOC commitment note extinguishment	476,000	0
Private Placement [Member]
Cash flows from financing activities:
Proceeds from private placement of Series D preferred stock, net of issuance costs	0	3,925,000
Series D Preferred Stock, Mezzanine Equity [Member]
Cash flows from financing activities:
Proceeds from private placement of Series D preferred stock, net of issuance costs	2,813,000	0
Series C Preferred Stock [Member]
Cash flows from financing activities:
Redemptions of Series C preferred stock	(517,000)	(847,000)
Supplementary disclosure of non-cash activity:
Conversion of Stock, Amount Converted	8,667,000	0
Deemed Dividends, Preferred Stock	5,513,000	0
Series D Preferred Stock [Member]
Cash flows from financing activities:
Redemptions of Series C preferred stock	(4,171,000)	0
Supplementary disclosure of non-cash activity:
Deemed Dividends, Preferred Stock	298,000
Varian Asset Acquisition [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
In-process research and development expenses in connection with the Varian asset acquisition	0	7,419,000
Varian Asset Acquisition [Member] | Series B Preferred Stock, Mezzanine Equity [Member]
Supplementary disclosure of non-cash activity:
Fair value of Series B Preferred Stock issued in connection with the Varian asset acquisition	$ 0	$ 7,022,000